The New York Times - Business:
The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.
Author: Rebecca Robbins
This post first appeared in The New York Times - Business. Read the original article.
